These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 25550892)
1. Stem cell-based therapies for age-related macular degeneration: current status and prospects. Mu Y; Zhao M; Su G Int J Clin Exp Med; 2014; 7(11):3843-52. PubMed ID: 25550892 [TBL] [Abstract][Full Text] [Related]
2. Stem cell therapies for age-related macular degeneration: the past, present, and future. Dang Y; Zhang C; Zhu Y Clin Interv Aging; 2015; 10():255-64. PubMed ID: 25609937 [TBL] [Abstract][Full Text] [Related]
3. Stem cell based therapies for age-related macular degeneration: The promises and the challenges. Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213 [TBL] [Abstract][Full Text] [Related]
4. Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration. Dehghan S; Mirshahi R; Shoae-Hassani A; Naseripour M Stem Cell Res Ther; 2022 May; 13(1):217. PubMed ID: 35619143 [TBL] [Abstract][Full Text] [Related]
5. Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside. Sachdeva MM; Eliott D Semin Ophthalmol; 2016; 31(1-2):25-9. PubMed ID: 26959126 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in the management of dry age-related macular degeneration: A review. Bandello F; Sacconi R; Querques L; Corbelli E; Cicinelli MV; Querques G F1000Res; 2017; 6():245. PubMed ID: 28529701 [TBL] [Abstract][Full Text] [Related]
11. Stemming retinal regeneration with pluripotent stem cells. Jin ZB; Gao ML; Deng WL; Wu KC; Sugita S; Mandai M; Takahashi M Prog Retin Eye Res; 2019 Mar; 69():38-56. PubMed ID: 30419340 [TBL] [Abstract][Full Text] [Related]
12. Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD). Surendran H; Rathod RJ; Pal R Methods Mol Biol; 2019; 2045():283-298. PubMed ID: 29896658 [TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cell-based therapy for age-related macular degeneration. Bracha P; Moore NA; Ciulla TA Expert Opin Biol Ther; 2017 Sep; 17(9):1113-1126. PubMed ID: 28664762 [TBL] [Abstract][Full Text] [Related]
14. Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD). Fields M; Cai H; Gong J; Del Priore L Cells; 2016 Dec; 5(4):. PubMed ID: 27941641 [TBL] [Abstract][Full Text] [Related]
15. Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy. Algvere PV; Berglin L; Gouras P; Sheng Y; Kopp ED Graefes Arch Clin Exp Ophthalmol; 1997 Mar; 235(3):149-58. PubMed ID: 9085110 [TBL] [Abstract][Full Text] [Related]
16. Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes. Zhao C; Boles NC; Miller JD; Kawola S; Temple S; Davis RJ; Stern JH J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829422 [TBL] [Abstract][Full Text] [Related]